JP2003535144A5 - - Google Patents

Download PDF

Info

Publication number
JP2003535144A5
JP2003535144A5 JP2002501471A JP2002501471A JP2003535144A5 JP 2003535144 A5 JP2003535144 A5 JP 2003535144A5 JP 2002501471 A JP2002501471 A JP 2002501471A JP 2002501471 A JP2002501471 A JP 2002501471A JP 2003535144 A5 JP2003535144 A5 JP 2003535144A5
Authority
JP
Japan
Prior art keywords
use according
administration
growth hormone
csf
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002501471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003535144A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/006249 external-priority patent/WO2001093900A1/en
Publication of JP2003535144A publication Critical patent/JP2003535144A/ja
Publication of JP2003535144A5 publication Critical patent/JP2003535144A5/ja
Withdrawn legal-status Critical Current

Links

JP2002501471A 2000-06-07 2001-06-01 多能性造血幹細胞の流動を刺激するヒト成長ホルモン Withdrawn JP2003535144A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00111834.8 2000-06-07
EP00111834 2000-06-07
PCT/EP2001/006249 WO2001093900A1 (en) 2000-06-07 2001-06-01 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (2)

Publication Number Publication Date
JP2003535144A JP2003535144A (ja) 2003-11-25
JP2003535144A5 true JP2003535144A5 (https=) 2008-07-10

Family

ID=8168902

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002501471A Withdrawn JP2003535144A (ja) 2000-06-07 2001-06-01 多能性造血幹細胞の流動を刺激するヒト成長ホルモン

Country Status (10)

Country Link
US (1) US20040028649A1 (https=)
EP (1) EP1286689B1 (https=)
JP (1) JP2003535144A (https=)
AT (1) ATE444078T1 (https=)
AU (2) AU8180001A (https=)
CA (1) CA2409197A1 (https=)
DE (1) DE60140051D1 (https=)
ES (1) ES2330193T3 (https=)
IL (1) IL153288A0 (https=)
WO (1) WO2001093900A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
EP1016413A1 (en) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
US7288521B2 (en) * 2000-04-06 2007-10-30 Franco Wayne P Growth factor therapy mobilization of stem cells into the peripheral blood
CA2467557A1 (en) * 2001-11-19 2003-05-30 Kyowa Hakko Kogyo Co., Ltd. Agent which mobilizes multipotential stem cells from tissues to peripheral blood
ES2781475T3 (es) 2002-09-18 2020-09-02 Janssen Pharmaceuticals Inc Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
US20040149235A1 (en) * 2002-10-04 2004-08-05 Pogue Albert S. Apparatus and method for removal of waste from animal production facilities
WO2005017160A2 (en) * 2003-08-13 2005-02-24 Children's Hospital Medical Center Mobilization of hematopoietic cells
WO2005017161A2 (en) 2003-08-13 2005-02-24 Children's Hospital Medical Center Chimeric peptides for the regulation of gtpases
US9011880B2 (en) 2003-10-21 2015-04-21 Igf Oncology, Llc Compounds and methods for treating cancer
CA2542834C (en) 2003-10-21 2012-04-24 Igf Oncology, Llc Conjugates or co-administration of igf-1 receptor ligands with anti-cancer chemotherapeutic agents
WO2005072292A2 (en) * 2004-01-24 2005-08-11 Hugh Mctavish Methods for enhancing radiation therapy
US7615533B2 (en) * 2004-08-16 2009-11-10 Janssen Pharmaceutica N.V. TPO peptide compounds for treatment of anemia
WO2006047214A2 (en) 2004-10-21 2006-05-04 Igf Oncology, Llc Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer
CA2677813A1 (en) * 2007-02-13 2008-08-21 Helsinn Therapeutics (U.S.), Inc. Method of treating cell proliferative disorders using growth hormone secretagogues
US20100226894A1 (en) * 2009-03-09 2010-09-09 Alex Wah Hin Yeung Mobilization of a complete cells mixture with embryonic like stem cells from the peripheral blood
SG192254A1 (en) * 2011-01-31 2013-08-30 Royal Medical Group Pllc Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
WO2012131733A2 (en) * 2011-03-31 2012-10-04 Godavari Biorefineries Limited Media compositions, method of initiating and enriching cultures of stem cells and/or cancer stem-like cells
CN104302670A (zh) 2012-02-07 2015-01-21 Phi生物医药股份有限公司 制造用于经皮给药的透明质酸-蛋白结合体的方法以及由该方法制造的用于经皮给药的透明质酸-蛋白结合体
CA2936675C (en) 2014-01-12 2023-06-27 Igf Oncology, Llc Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
CN117442747A (zh) 2017-05-21 2024-01-26 Igf肿瘤公司 胰岛素样生长因子——用于治疗骨髓增生异常综合症的化学治疗缀合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549232C2 (de) * 1995-12-20 1998-05-20 Boehringer Mannheim Gmbh Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum bei der Behandlung von Erkrankungen, die eine periphere Stammzelltransplantation erfordern
EP1016414B1 (en) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
EP1016413A1 (en) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Similar Documents

Publication Publication Date Title
JP2003535144A5 (https=)
Kurzrock et al. Phase I study of recombinant human interleukin-3 in patients with bone marrow failure.
EP2324109B1 (en) Expansion of haemopoietic precursors
ES2380009T3 (es) Métodos para movilizar las células madre/progenitoras
CN104884076B (zh) 利用了hmgb1片段的心肌梗塞的治疗方法
CA2109699A1 (en) Method for improving autologous transplantation
EP0593625B1 (en) Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity
MXPA06000017A (es) Combinacion farmaceutica de factor estimulador de colonias de granulocitos y factor de crecimiento placentario util para hemocitoblastos.
EP2344527A1 (en) Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor
JP5205668B2 (ja) 可動化活性を有する調製物
Roodman et al. Tumor necrosis factor α and the anemia of chronic disease: Effects of chronic exposure to TNF on erythropoiesis in vivo
CN115210363B (zh) 用于增强干细胞功能的组合物
JP2001526689A (ja) トロンボポエチンの新規な投与
Bishop et al. Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.
WO1994018991A1 (en) EXPANSION OF STEM CELLS IN LONG TERM BONE MARROW CULTURES BY NEUTRALIZATION OF TGF-$g(b)
JPH05252940A (ja) 形質転換成長因子βを使用した、マクロファージおよび顆粒球の再集団化
JP4414494B2 (ja) 白血球減少症の予防剤および治療剤
WO2004091661A1 (ja) 糖尿病治療剤
Schriber et al. Use and toxicity of the colony-stimulating factors
Singh et al. Role of erythropoietin and other growth factors in ex vivo erythropoiesis
Drings et al. Biology and clinical use of GM-CSF in lung cancer
JP2003521439A5 (https=)
Holldack et al. Biology and pharmacology of hematopoietic growth factors
Morstyn et al. Clinical applications of filgrastim and stem cell factor in vivo and in vitro
Mehta et al. High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary results